Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Placental and juvenile immune responses to maternal immune activation are differentially regulated by sex chromosomes and gonads across gestation.

Journal of neuroinflammation·2026
Same author

Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Sex and life experience shape locus coeruleus pretangle tau pathology.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Perinatal hyperandrogenization and immune activation in rodents model subtypes of autism.

Translational psychiatry·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Refined ChIP-Seq Protocol for High-Quality Chromatin Profiling in Solid Tissues Using the Complete Genomics/MGI Sequencing Platform.

Current protocols·2025

Related Experiment Video

Updated: May 14, 2026

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

11.2K

Locus coeruleus vulnerability to tau hyperphosphorylation in a rat model.

Tamunotonye Omoluabi1, Zia Hasan1, Jessie E Piche1,2

  • 1Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.

Aging Cell
|November 9, 2024
PubMed
Summary

Alzheimer's disease research reveals that tau pathology in the locus coeruleus (LC) impairs neuron function and causes cognitive deficits. Blocking L-type calcium channels (LTCCs) may offer a therapeutic strategy for tau-induced neurodegeneration.

Keywords:
L‐type calcium channelelectron microscopylocus coeruleusmitochondriasingle nuclei RNA sequencingtau

More Related Videos

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

8.9K
An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
05:51

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

5.9K

Related Experiment Videos

Last Updated: May 14, 2026

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

11.2K
Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

8.9K
An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
05:51

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

5.9K

Area of Science:

  • Neuroscience
  • Pathology
  • Genomics

Background:

  • The locus coeruleus (LC) is the first brain region affected by tau pathology in Alzheimer's disease (AD).
  • Degeneration of LC neurons correlates with cognitive decline in AD, but mechanisms remain unclear.
  • Pretangle tau, a precursor to neurofibrillary tangles (NFTs), is implicated in AD pathogenesis.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying pretangle tau-induced degeneration of LC noradrenergic neurons.
  • To examine the impact of tau pathology on neuronal transcriptomics and mitochondrial function.
  • To explore potential therapeutic targets for mitigating tau-induced LC dysfunction.

Main Methods:

  • Transcriptomic and mitochondrial profiling of LC neurons in rats transduced with pseudophosphorylated human tau.
  • Assessment of spatial and olfactory learning deficits.
  • Evaluation of the effects of chronic L-type calcium channel (LTCC) blockade.

Main Results:

  • Tau hyperphosphorylation upregulated L-type calcium channel (LTCC) expression in LC neurons.
  • Impaired mitochondrial health and deficits in spatial and olfactory learning were observed.
  • Sex-dependent gene expression alterations were noted, and LTCC blockade ameliorated behavioral deficits and altered mitochondrial mRNA expression.

Conclusions:

  • Tau pathology in the LC leads to LTCC hyperactivity, mitochondrial dysfunction, and cognitive impairment.
  • LTCCs represent a potential therapeutic target for addressing early tau pathology in Alzheimer's disease.
  • Understanding tau's effects on the LC is crucial for developing effective AD treatments.